Quick answer: Fasting insulin measures circulating insulin, while HOMA-IR combines fasting insulin and glucose to estimate insulin resistance indirectly. This calculation is mainly a research or selected specialist tool, not a stand-alone diabetes diagnosis or routine population screen. Assay differences and the person’s metabolic state matter. QXL must confirm the fasting protocol, included glucose measurement, calculation and report time.
Also known as: fasting insulin, HOMA1-IR, homeostasis model assessment, insulin resistance estimate
What is the Fasting Insulin / HOMA-IR test used for?#
- Selected specialist assessment when an insulin measurement answers a defined metabolic question.
- Research or locally validated pathways that explicitly require a fasting insulin/glucose index.
- Evaluation of hypoglycaemia may use insulin, but requires a different supervised sampling and interpretation protocol.
Conditions it helps investigate: Insulin resistance
What does the test measure?#
- Fasting insulin: Hormone concentration influenced by secretion, clearance, medicines and assay specificity.
- Fasting plasma glucose: Glucose concentration required from the same fasting assessment for HOMA1-IR.
- HOMA1-IR calculation: An indirect model-derived estimate; not a direct measurement of tissue insulin action.
How is it tested?#
Insulin is commonly measured by immunoassay; glucose uses a validated chemistry method. HOMA1-IR = fasting insulin (µU/mL) × fasting glucose (mmol/L) / 22.5, or × glucose (mg/dL) / 405. HOMA2 is a different model and must not be labelled as this simple formula. Confirm which assay and calculation QXL actually reports.
Sample and preparation#
Specimen: Venous blood; serum or plasma suitability must be confirmed for the actual QXL assay.
- Arrange the fasting interval specified by QXL and your clinician; both measurements must represent the same fasting state.
- Record insulin use, glucose-lowering medicines, acute illness and last food intake; obtain an individual medicine plan.
- Do not extend fasting or omit treatment yourself, especially if pregnant, unwell or at risk of hypoglycaemia.
| Specimen detail | What to confirm |
|---|---|
| Volume | Confirm minimum and paediatric volume with QXL test master. |
| Container | Use the collection tube or container specified by the actual QXL test SOP. |
| Stability | Confirm separation deadline, validated transport temperature, cold-chain and stability window with QXL. |
| Rejection | QXL must confirm identification, specimen quality, quantity and transport acceptance criteria. |
How are the results interpreted?#
- Higher HOMA1-IR may reflect lower insulin sensitivity in an appropriate study or validated context; no universal clinical threshold applies.
- Insulin secretion, clearance, glycaemic state and assay calibration affect the index.
- Glucose and HbA1c, blood pressure, adiposity and lipids often provide more useful routine risk information.
Reference interval: Use the method, units and context-specific interval or decision limits on the actual laboratory report; no universal numeric normal range is substituted.
What are the limitations?#
- Routine insulin testing for most people with diabetes or cardiovascular risk is not recommended by laboratory diabetes guidance.
- Injected insulin, severe insulin deficiency, unstable glucose or acute illness may undermine the model’s assumptions.
- An index cannot establish diabetes, PCOS or a specific tissue-level defect.
How does it compare with other tests?#
- HOMA-IR is an indirect fasting estimate; a hyperinsulinaemic euglycaemic clamp is a specialist research measurement.
- HbA1c, fasting plasma glucose and an indicated oral glucose tolerance test answer established dysglycaemia questions.
Notes for referring clinicians#
State the clinical question, relevant treatment and specimen timing. Discuss unexpected or discordant results with the laboratory before changing management.
Price, report time and home collection#
- Price: Request the current QXL quote, included components and any collection charges.
- Report time: Confirm test-specific QXL reporting time, its starting point, working-day conditions and any referral transit before collection.
- Home collection: Ask QXL to confirm Bengaluru pincode eligibility, test suitability, collection timing and whether the visit is free.
- Processing: QXL verification pending: performing laboratory, platform and in-house versus referral status.
- Report review: Appropriately qualified laboratory authorisation is required. Ask QXL whether a separate report-discussion appointment is available. This content has not received medical sign-off.
Call +91 9964 639 639 or WhatsApp QXL to confirm the current quote, preparation and collection slot.
Frequently asked questions#
Is HOMA-IR a diabetes diagnostic test?#
No. It estimates a component of insulin resistance and does not replace established glucose or HbA1c pathways.
How is HOMA1-IR calculated?#
Use fasting insulin in µU/mL multiplied by fasting glucose in mmol/L, divided by 22.5; with glucose in mg/dL divide by 405.
Is HOMA2 the same calculation?#
No. HOMA2 is a different computer model; reports must identify which model and inputs were used.
What HOMA-IR value is normal?#
There is no universal threshold across assays, ages and populations. Use a clinically justified, locally validated interpretation.
Can I calculate it from a random glucose?#
No. The simple HOMA1 model requires fasting insulin and fasting glucose from the same fasting assessment.
Can I use this while injecting insulin?#
Injected insulin can affect assay results and model validity. Discuss a suitable assessment with your clinician.
Should everyone with PCOS request fasting insulin?#
No. Routine insulin testing is not recommended simply because PCOS is suspected; the clinician should define the question.
What should I confirm before booking?#
Confirm fasting instructions, medicine safety, glucose inclusion, model name, current price and test-specific QXL reporting time.
Related test guides#
Sources#
- Tietz ninth edition, PDF pages 1734–1736 and 1744: limited routine insulin utility and indirect HOMA assessment.
- Diabetes Care laboratory recommendations (2023) cross-check routine-use limits; Wallace et al. (2004) provides HOMA1 units and equation.
Educational information only; not a diagnosis or a substitute for a doctor’s advice.
Medical & Laboratory Disclaimer
Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.
Dr. Shantakumar Muruda
MD (Biochemistry), Founder & CEO
QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.

